Compounded Semaglutide vs Wegovy: What the FDA Says and What to Ask

Disclosure: This post contains affiliate links. If you purchase through them, we may earn a commission at no extra cost to you. We only recommend products that meet our evidence standard.

Compounded semaglutide vs Wegovy is really a question about paperwork. Same drug name, very different approval status, oversight and price.

Here’s what the FDA says, with dates.

What Does Compounded Semaglutide Mean?

It means a pharmacy mixed the medication itself instead of buying it from the manufacturer. The FDA defines compounding as a licensed pharmacist or physician combining, mixing or altering ingredients to create a medication tailored to an individual patient.

Wegovy is made by Novo Nordisk and comes as a pre-filled injection or a daily tablet. The FDA says compounded GLP-1s may be dispensed in multi-dose vials that you draw up yourself.

That detail matters more than it sounds. With a pre-filled pen or a tablet, the dose is set for you. With a vial, you’re measuring it.

Is Compounded Semaglutide FDA Approved?

No. In the FDA’s own words, compounded drugs are not FDA approved, and the agency does not review them for safety, effectiveness or quality before they’re marketed.

That doesn’t make every compounded product bad. It means nobody outside the pharmacy checked it the way the FDA checks Wegovy.

The FDA’s page on unapproved GLP-1 drugs, updated September 1, 2026, lists 990 adverse event reports involving compounded semaglutide and more than 730 for compounded tirzepatide. It says some came from dosing errors, where patients measured the wrong amount or a professional miscalculated.

Is Compounded Semaglutide Being Banned?

Not banned, but squeezed hard. During the shortage, pharmacies were allowed to make copies of the brand-name drug. That window has closed.

Here’s the timeline from the FDA:

• February 21, 2025: the FDA determined the semaglutide injection shortage was resolved.
• April 22, 2025: the grace period ended for state-licensed 503A pharmacies.
• May 22, 2025: the grace period ended for 503B outsourcing facilities.
• April 30, 2026: the FDA proposed excluding semaglutide, tirzepatide and liraglutide from the list of bulk ingredients 503B facilities may compound with. Comments closed June 29, 2026. No final decision is recorded on that page yet.

Tirzepatide went through the same thing earlier. Its shortage was declared resolved December 19, 2024.

So how is compounded semaglutide still sold? The FDA says a compounder can still make it when a prescriber determines and documents that the compounded version has a change that makes a significant difference for an identified individual patient.

What’s the Difference Between a 503A and a 503B Pharmacy?

A 503A pharmacy compounds against a valid prescription for an individual patient. It’s a state-licensed pharmacy.

A 503B outsourcing facility registers with the FDA, gets inspected by the FDA and has to meet Current Good Manufacturing Practice rules. That’s closer to how a drug manufacturer operates.

Neither one makes the product FDA-approved. But a 503B facility sits under more federal oversight, and the FDA publishes its registered facilities with inspection history.

Is Compounded Semaglutide as Effective as Wegovy?

Nobody can tell you that with trial data, because compounded versions don’t go through FDA review. Wegovy’s results come from Wegovy. They don’t automatically transfer to a vial made somewhere else.

There’s one more thing to watch. Compounded GLP-1s are not FDA-approved, and the FDA says salt forms such as semaglutide sodium and semaglutide acetate are different active ingredients from the ones in the approved drugs. Ask what’s in yours.

How Much Is Compounded Semaglutide vs Wegovy?

As of September 2026, first-time patients can start GobyMeds with a three-month bundle: $299 for compounded semaglutide or $399 for compounded tirzepatide, which works out to $99 and $133 a month. A single month is listed from $169 for semaglutide and from $299 for tirzepatide, and higher doses cost more. Brand-name Zepbound is listed at $1,399 a month and Wegovy at $1,695 a month. There’s no subscription, and prescriptions are final sale.

NovoCare sells Wegovy pens self-pay at $349 a month for doses up to 2.4 mg ($399 for the 7.2 mg HD dose), and Wegovy tablets from $149 to $299 a month. New patients get the two starting pen doses at $199 a month for two fills through December 31, 2026.

Against the pen the gap is about $250 a month. Against the tablet it’s much smaller, roughly $50 to $200.

One note for men getting close to 65: NovoCare lists at least one of its savings offers as excluding government beneficiaries. If you’re on Medicare, confirm your price before you plan around it.

How Do I Check a Compounding Pharmacy’s License?

Go to your state board of pharmacy’s license lookup and search the pharmacy’s name. The FDA’s BeSafeRx page links to each state’s database and says that if the pharmacy isn’t listed, don’t use it.

If it is listed, the FDA says to confirm three things: it requires a prescription, it has a physical address and phone number in the United States, and a licensed pharmacist is available to answer your questions.

If it’s a 503B facility, check the FDA’s registered outsourcing facilities list too.

What Should a Man Over 50 Ask Before Ordering Compounded Semaglutide?

Ask these before you pay, not after the vial shows up:

• Which pharmacy fills my prescription, and is it 503A or 503B?
• Is it semaglutide itself, or a salt form like semaglutide sodium or acetate?
• Does it come in a vial or a pen, and exactly how do I measure each dose?
• What’s documented as the clinical reason I’m getting a compounded version instead of Wegovy?
• Who reviews my current medications, and who do I contact if a dose isn’t working?

If you’re already on blood pressure, cholesterol or diabetes medication, that list gets more important, not less. Your dose decisions belong with the prescriber who has your full history.

A good provider answers all five without getting defensive. If you want to see how one telehealth service handles this, GobyMeds lists its compounded and brand-name options here, and our GobyMeds review covers its pricing and pharmacy questions in more detail. It’s worth putting ShedRX next to it before you commit.

Compounded isn’t the villain and brand-name isn’t magic. One is FDA-approved and costs more. The other costs less and puts more of the checking on you.

Related Reading

• GLP-1 side effects for men over 50: whichever version you pick, this is what the first few weeks can actually feel like.
• GobyMeds semaglutide vs tirzepatide: once you’ve sorted compounded versus brand-name, this is the next decision on the list.